Analystreport

GlaxoSmithKline plc (NYSE: GSK) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors